Skip to main content
. 2014 Oct;351(1):44–53. doi: 10.1124/jpet.114.216036

Fig. 8.

Fig. 8.

Schematic presentation of the neurochemical (RVLM) and BP responses elicited by activating central GPR18. Activation of intra-RVLM GPR18 inhibits cAMP leading to enhanced pERK1/2 and pAkt production, which causes p-nNOS (NO)–dependent elevation in ADN, and ultimately reductions in RVLM ROS and BP.